(Q49215044)

19 February 2018

title

Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. (English)

1 reference

19 February 2018

1 reference

M Y Follo

1

1 reference

19 February 2018

S Mongiorgi

2

1 reference

19 February 2018

C Clissa

3

1 reference

19 February 2018

S Paolini

4

1 reference

19 February 2018

G Martinelli

5

1 reference

19 February 2018

A M Martelli

6

1 reference

19 February 2018

G Fioravanti

7

1 reference

19 February 2018

L Manzoli

8

1 reference

19 February 2018

C Finelli

9

1 reference

19 February 2018

L Cocco

10

1 reference

19 February 2018

publication date

18 May 2012

1 reference

19 February 2018

published in

Leukemia

1 reference

19 February 2018

volume

26

1 reference

19 February 2018

issue

12

1 reference

19 February 2018

page(s)

2474-2482

1 reference

19 February 2018

https://scigraph.springernature.com/pub.10.1038/leu.2012.133

exact match

0 references

cites work

Myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

The physiology and pathology of inositide signaling in the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

A role for nuclear phospholipase Cbeta 1 in cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Cell cycle control genes and hematopoietic cell differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

A unique function for cyclin D3 in early B cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Revisiting nuclear phospholipase C signalling in MDS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Erythropoiesis-stimulating agents

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Unraveling the molecular pathophysiology of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Erythropoietin in heart and vessels: focus on transcription and signalling pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Akt binds to and phosphorylates phospholipase C-gamma1 in response to epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Expression of signal transduction proteins during the differentiation of primary human erythroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.133

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.133

1 reference

19 February 2018

Dimensions Publication ID

1031680911

0 references

1 reference

19 February 2018